• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白90抑制剂,第1部分:三维定量构效关系自动对接格点/模型作为虚拟筛选工具的定义。

Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening.

作者信息

Ballante Flavio, Caroli Antonia, Wickersham Richard B, Ragno Rino

机构信息

Rome Center for Molecular Design, Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma , P. le A. Moro 5, 00185 Roma, Italy.

出版信息

J Chem Inf Model. 2014 Mar 24;54(3):956-69. doi: 10.1021/ci400759t. Epub 2014 Mar 4.

DOI:10.1021/ci400759t
PMID:24564321
Abstract

The multichaperone heat shock protein (Hsp) 90 complex mediates the maturation and stability of a variety of oncogenic signaling proteins. For this reason, Hsp90 has emerged as a promising target for anticancer drug development. Herein, we describe a complete computational procedure for building several 3-D QSAR models used as a ligand-based (LB) component of a comprehensive ligand-based (LB) and structure-based (SB) virtual screening (VS) protocol to identify novel molecular scaffolds of Hsp90 inhibitors. By the application of the 3-D QSAutogrid/R method, eight SB PLS 3-D QSAR models were generated, leading to a final multiprobe (MP) 3-D QSAR pharmacophoric model capable of recognizing the most significant chemical features for Hsp90 inhibition. Both the monoprobe and multiprobe models were optimized, cross-validated, and tested against an external test set. The obtained statistical results confirmed the models as robust and predictive to be used in a subsequent VS.

摘要

多分子伴侣热休克蛋白(Hsp)90复合物介导多种致癌信号蛋白的成熟和稳定性。因此,Hsp90已成为抗癌药物开发的一个有前景的靶点。在此,我们描述了一个完整的计算程序,用于构建几个三维定量构效关系(3-D QSAR)模型,作为基于配体(LB)和基于结构(SB)的综合虚拟筛选(VS)方案的基于配体(LB)部分,以识别Hsp90抑制剂的新型分子骨架。通过应用3-D QSAutogrid/R方法,生成了八个SB PLS 3-D QSAR模型,得到了一个最终的多探针(MP)3-D QSAR药效团模型,该模型能够识别Hsp90抑制作用中最重要的化学特征。单探针和多探针模型均经过优化、交叉验证,并针对外部测试集进行了测试。获得的统计结果证实这些模型稳健且具有预测性,可用于后续的虚拟筛选。

相似文献

1
Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening.热休克蛋白90抑制剂,第1部分:三维定量构效关系自动对接格点/模型作为虚拟筛选工具的定义。
J Chem Inf Model. 2014 Mar 24;54(3):956-69. doi: 10.1021/ci400759t. Epub 2014 Mar 4.
2
Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application.热休克蛋白90抑制剂,第2部分:结合基于配体和基于结构的方法用于虚拟筛选应用。
J Chem Inf Model. 2014 Mar 24;54(3):970-7. doi: 10.1021/ci400760a. Epub 2014 Mar 4.
3
3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.基于 3D QSAR 药效团的虚拟筛选和分子对接鉴定潜在 HSP90 抑制剂。
Eur J Med Chem. 2010 Jun;45(6):2132-40. doi: 10.1016/j.ejmech.2010.01.016. Epub 2010 Feb 4.
4
Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors.基于药效团的虚拟筛选、分子对接研究以设计有效的热休克蛋白90抑制剂。
Eur J Med Chem. 2011 Jul;46(7):2937-47. doi: 10.1016/j.ejmech.2011.04.018. Epub 2011 Apr 15.
5
Molecular design of anticancer drug leads based on three-dimensional quantitative structure-activity relationship.基于三维定量构效关系的抗癌药物先导分子设计。
J Chem Inf Model. 2011 Aug 22;51(8):1999-2006. doi: 10.1021/ci2002236. Epub 2011 Jul 26.
6
Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.通过片段组合方法、虚拟筛选和基于结构的药物设计来产生热休克蛋白 90 抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5778-83. doi: 10.1016/j.bmcl.2011.08.001. Epub 2011 Aug 6.
7
Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors.基于药效团的 Hsp90 抑制剂虚拟筛选和对接研究。
SAR QSAR Environ Res. 2010 Jul;21(5-6):445-62. doi: 10.1080/1062936X.2010.501817.
8
Structure based design of heat shock protein 90 inhibitors acting as anticancer agents.基于结构的热休克蛋白 90 抑制剂设计及其作为抗癌剂的作用。
Bioorg Med Chem. 2011 Mar 1;19(5):1714-20. doi: 10.1016/j.bmc.2011.01.023. Epub 2011 Jan 19.
9
Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents.通过 3-D QSAR 进行药效团评估:通过对一系列抗结核药物的应用评估对新衍生物的预测能力。
J Chem Inf Model. 2013 Jun 24;53(6):1463-74. doi: 10.1021/ci400132q. Epub 2013 May 17.
10
Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors.基于配体的详细建模揭示了新的纳摩尔热休克蛋白 90α 抑制剂。
J Chem Inf Model. 2010 Sep 27;50(9):1706-23. doi: 10.1021/ci100222k.

引用本文的文献

1
Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years.热休克蛋白 90(HSP90)抑制剂作为抗癌药物:过去五年计算机辅助药物发现方法的综述。
Comput Math Methods Med. 2022 May 31;2022:2147763. doi: 10.1155/2022/2147763. eCollection 2022.
2
Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants.人雌激素受体α拮抗剂,第 3 部分:3-D 药效团和 3-D QSAR 指导布雷菲德菌素 A 从头化合物优化,以开发新型乳腺癌抑制剂。
Molecules. 2022 Apr 28;27(9):2823. doi: 10.3390/molecules27092823.
3
Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules.
靶向抗凋亡 Bcl-2 家族蛋白:新小分子的机器学习虚拟筛选和生物学评价。
Theranostics. 2022 Feb 28;12(5):2427-2444. doi: 10.7150/thno.64233. eCollection 2022.
4
Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.端粒沉默抑制因子 1 样蛋白(DOT1L):通过配体和基于结构的方法揭示一类新型非核苷抑制剂。
J Comput Aided Mol Des. 2018 Mar;32(3):435-458. doi: 10.1007/s10822-018-0096-z. Epub 2018 Jan 15.
5
Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.基于3,4-异恶唑二酰胺骨架,运用定量构效关系研究、分子对接和分子动力学模拟对新型Hsp90抑制剂进行预测。
Daru. 2017 Jun 30;25(1):17. doi: 10.1186/s40199-017-0182-0.
6
Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives.新型5-氢磺酰基-1H-苯并[d]咪唑-2(3H)-酮衍生物的合成与抗肿瘤评价
Molecules. 2016 Apr 20;21(4):516. doi: 10.3390/molecules21040516.
7
Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches.血管内皮生长因子受体-2(VEGFR-2)抑制剂:通过广泛的基于配体和结构的方法开发和验证预测性三维定量构效关系模型
J Comput Aided Mol Des. 2015 Aug;29(8):757-76. doi: 10.1007/s10822-015-9859-y. Epub 2015 Jul 21.
8
Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design.基于结构的药物设计中蛋白质-配体对接的挑战、应用及最新进展。
Molecules. 2014 Jul 11;19(7):10150-76. doi: 10.3390/molecules190710150.
9
Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application.热休克蛋白90抑制剂,第2部分:结合基于配体和基于结构的方法用于虚拟筛选应用。
J Chem Inf Model. 2014 Mar 24;54(3):970-7. doi: 10.1021/ci400760a. Epub 2014 Mar 4.